DEFA14A: Coherus BioSciences Sets Date for 2025 Annual Meeting, Outlines Proposals for Stockholder Vote

Coherus BioSciences announces its 2025 Annual Meeting of Stockholders to be held on June 11, 2025, outlining key proposals for voting, including the election of directors, ratification of the auditor, executive compensation approval, and an amendment to the employee stock purchase plan.

Summary

• Coherus BioSciences will hold its Annual Meeting of Stockholders on June 11, 2025, at 1:30 p.m. PDT.
• The meeting will be held virtually at www.virtualshareholdermeeting.com/CHRS2025.
• Stockholders are being asked to vote on several key proposals.
• These proposals include the election of three Class II directors to hold office until the 2028 Annual Meeting.
• The nominees are Jill ODonnell-Tormey, Ph.D., Michael Ryan, and Ali J. Satvat.
• Another proposal is to ratify the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Stockholders will also vote on a non-binding, advisory basis to approve the compensation of the company's named executive officers (a Say-on-Pay vote).
• Finally, there is a proposal to approve the amendment to the company's 2014 Employee Stock Purchase Plan (ESPP Amendment).
• Stockholders can request a free paper or email copy of the meeting materials prior to May 28, 2025, by visiting www.ProxyVote.com, calling 1-800-579-1639, or emailing sendmaterial@proxyvote.com.

Sentiment

Score: 7

Explanation: The document is a routine proxy statement, indicating a neutral but necessary corporate process. The proposals are standard, and the information is presented clearly.

Positives

• The company is providing multiple avenues for stockholders to access proxy materials and vote, including online, phone, and email.
• The proposals are clearly outlined, allowing stockholders to make informed decisions.

Future Outlook

The document outlines the business to be conducted at the upcoming annual meeting.

Industry Context

This announcement is standard practice for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions regarding the company's governance and direction.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• Employees may be impacted by the approval of the ESPP amendment.
• The selection of the auditor impacts the credibility of the company's financial reporting.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on June 11, 2025, and tabulate the votes.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Coherus BioSciences, Directors, Auditor, Executive Compensation, ESPP, Voting